GlaxoSmithKline Pharmaceuticals has received a demand order from Maharashtra State GST authorities for FY 2021-22, totaling ₹35,07,895. This includes tax of ₹18,16,196, interest of ₹15,10,080, and a penalty of ₹1,81,619. The company is evaluating the order and will take appropriate actions.
GST Demand Order Details
GlaxoSmithKline Pharmaceuticals received an order on December 31st, 2025, from the Assistant Commissioner of State Tax, Mumbai, Maharashtra, related to GST for the financial year 2021-22.
Financial Impact
The total demand amounts to ₹35,07,895, breaking down as follows:
Tax: ₹18,16,196
Interest: ₹15,10,080
Penalty: ₹1,81,619
Reason for Demand
The demand has been raised due to a mismatch between the Company’s GST returns and the details reported by suppliers regarding GST credit related issues.
Company Response
The Company reports that there is no immediate impact on its financial operations and is currently evaluating the demand order. Appropriate actions will be taken in due course.
Source: BSE
